Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-07-03

Clinical Trial Update: Inflammation in Type 2 Myocardial Infarction

View source ↗

Summary

This clinical trial investigating inflammation in Type 2 myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Myocardial Infarction, Inflammation | Status: WITHDRAWN